Zanella, A.B.; Marmitt, L.; Fighera, T.M.; Scheffel, R.S.; Spritzer, P.M.; Dora, J.M.; Maia, A.L.
Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma. Metabolites 2022, 12, 842.
https://doi.org/10.3390/metabo12090842
AMA Style
Zanella AB, Marmitt L, Fighera TM, Scheffel RS, Spritzer PM, Dora JM, Maia AL.
Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma. Metabolites. 2022; 12(9):842.
https://doi.org/10.3390/metabo12090842
Chicago/Turabian Style
Zanella, André Borsatto, Laura Marmitt, Tayane Muniz Fighera, Rafael Selbach Scheffel, Poli Mara Spritzer, José Miguel Dora, and Ana Luiza Maia.
2022. "Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma" Metabolites 12, no. 9: 842.
https://doi.org/10.3390/metabo12090842
APA Style
Zanella, A. B., Marmitt, L., Fighera, T. M., Scheffel, R. S., Spritzer, P. M., Dora, J. M., & Maia, A. L.
(2022). Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma. Metabolites, 12(9), 842.
https://doi.org/10.3390/metabo12090842